Latest Insider Transactions at Catalent, Inc. (CTLT)
This section provides a real-time view of insider transactions for Catalent, Inc. (CTLT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Catalent, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Catalent, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 26
2021
|
Michael J Grippo SVP, Strategy & Corp. Dev. |
BUY
Grant, award, or other acquisition
|
Direct |
4,984
+23.47%
|
-
|
|
Aug 26
2021
|
Scott Gunther SVP, Quality & Reg. Affairs |
BUY
Grant, award, or other acquisition
|
Direct |
6,052
+21.4%
|
-
|
|
Aug 26
2021
|
Alessandro Maselli President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
8,008
+21.27%
|
-
|
|
Aug 26
2021
|
Ricardo Pravda Chief Transformation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,030
+13.05%
|
-
|
|
Aug 26
2021
|
Ricky Hopson Pres. BioProduct Delivery, CoS |
BUY
Grant, award, or other acquisition
|
Direct |
4,317
+17.14%
|
-
|
|
Aug 26
2021
|
Kay A Schmidt SVP, Enterprise Functions |
BUY
Grant, award, or other acquisition
|
Direct |
2,590
+13.36%
|
-
|
|
Aug 26
2021
|
Thomas P Castellano SVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,273
+17.75%
|
-
|
|
Jul 26
2021
|
Jonathan Arnold SVP, CCO & Div. Head BioP Del. |
BUY
Grant, award, or other acquisition
|
Direct |
885
+2.2%
|
-
|
|
Jul 26
2021
|
Jonathan Arnold SVP, CCO & Div. Head BioP Del. |
SELL
Open market or private sale
|
Direct |
120
-0.31%
|
$13,560
$113.05 P/Share
|
|
Jul 26
2021
|
John R Chiminski Executive Chair |
BUY
Grant, award, or other acquisition
|
Direct |
16,461
+8.88%
|
-
|
|
Jul 26
2021
|
John R Chiminski Executive Chair |
SELL
Open market or private sale
|
Direct |
11,137
-6.81%
|
$1,258,481
$113.05 P/Share
|
|
Jul 26
2021
|
Steven L Fasman EVP & Chief Admin Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,770
+2.5%
|
-
|
|
Jul 26
2021
|
Steven L Fasman EVP & Chief Admin Officer |
SELL
Open market or private sale
|
Direct |
1,549
-2.25%
|
$175,037
$113.05 P/Share
|
|
Jul 26
2021
|
Karen Flynn Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,151
+3.12%
|
-
|
|
Jul 26
2021
|
Aristippos Gennadios Group Pres. Pharma & Consumer |
BUY
Grant, award, or other acquisition
|
Direct |
885
+1.68%
|
-
|
|
Jul 26
2021
|
Aristippos Gennadios Group Pres. Pharma & Consumer |
SELL
Open market or private sale
|
Direct |
465
-0.91%
|
$52,545
$113.05 P/Share
|
|
Jul 26
2021
|
Michael J Grippo SVP, Strategy & Corp. Dev. |
BUY
Grant, award, or other acquisition
|
Direct |
974
+5.25%
|
-
|
|
Jul 26
2021
|
Michael J Grippo SVP, Strategy & Corp. Dev. |
SELL
Open market or private sale
|
Direct |
451
-2.64%
|
$50,963
$113.05 P/Share
|
|
Jul 26
2021
|
Scott Gunther SVP, Quality & Reg. Affairs |
BUY
Grant, award, or other acquisition
|
Direct |
753
+4.45%
|
-
|
|
Jul 26
2021
|
Scott Gunther SVP, Quality & Reg. Affairs |
SELL
Open market or private sale
|
Direct |
1,079
-3.32%
|
$121,927
$113.04 P/Share
|
|
Jul 26
2021
|
Alessandro Maselli President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
3,009
+12.21%
|
-
|
|
Jul 26
2021
|
Alessandro Maselli President & CEO |
SELL
Open market or private sale
|
Direct |
993
-5.06%
|
$112,209
$113.05 P/Share
|
|
Jul 26
2021
|
Ricardo Pravda Chief Transformation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
885
+7.15%
|
-
|
|
Jul 26
2021
|
Ricardo Pravda Chief Transformation Officer |
SELL
Open market or private sale
|
Direct |
458
-4.14%
|
$51,754
$113.05 P/Share
|
|
Jul 26
2021
|
Ricky Hopson Pres. BioProduct Delivery, CoS |
BUY
Grant, award, or other acquisition
|
Direct |
496
+2.91%
|
-
|
|
Jul 26
2021
|
Ricky Hopson Pres. BioProduct Delivery, CoS |
SELL
Open market or private sale
|
Direct |
360
-2.19%
|
$40,680
$113.05 P/Share
|
|
Jul 26
2021
|
Kay A Schmidt SVP, Enterprise Functions |
BUY
Grant, award, or other acquisition
|
Direct |
885
+5.87%
|
-
|
|
Jul 26
2021
|
Kay A Schmidt SVP, Enterprise Functions |
SELL
Open market or private sale
|
Direct |
547
-3.94%
|
$61,811
$113.05 P/Share
|
|
Jul 26
2021
|
Thomas P Castellano SVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,062
+6.4%
|
-
|
|
Jul 26
2021
|
Thomas P Castellano SVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
555
-3.7%
|
$62,715
$113.05 P/Share
|
|
Jul 26
2021
|
Ricci S Whitlow President, CSS |
BUY
Grant, award, or other acquisition
|
Direct |
531
+14.6%
|
-
|
|
Jul 15
2021
|
Steven L Fasman EVP & Chief Admin Officer |
SELL
Open market or private sale
|
Direct |
4,500
-3.1%
|
$495,000
$110.05 P/Share
|
|
Jun 23
2021
|
Ricardo Pravda Chief Transformation Officer |
SELL
Open market or private sale
|
Direct |
2,800
-20.19%
|
$308,000
$110.58 P/Share
|
|
Jun 01
2021
|
Ricky Hopson Pres. BioProduct Delivery, CoS |
BUY
Grant, award, or other acquisition
|
Direct |
3,432
+17.37%
|
-
|
|
Jun 01
2021
|
Thomas P Castellano SVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,451
+14.03%
|
-
|
|
May 10
2021
|
Michael J Grippo SVP, Strategy & Corp. Dev. |
SELL
Bona fide gift
|
Direct |
20
-0.06%
|
-
|
|
Apr 28
2021
|
Michael J Barber |
BUY
Grant, award, or other acquisition
|
Direct |
845
+50.0%
|
-
|
|
Mar 22
2021
|
Kay A Schmidt SVP, Enterprise Functions |
SELL
Open market or private sale
|
Direct |
1,400
-9.17%
|
$147,000
$105.77 P/Share
|
|
Mar 19
2021
|
John R Chiminski Executive Chair |
SELL
Open market or private sale
|
Direct |
183,024
-20.43%
|
$19,400,544
$106.32 P/Share
|
|
Mar 19
2021
|
John R Chiminski Executive Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
183,024
+14.38%
|
$7,687,008
$42.44 P/Share
|
|
Mar 18
2021
|
John R Chiminski Executive Chair |
SELL
Open market or private sale
|
Direct |
42,220
-20.51%
|
$4,433,100
$105.16 P/Share
|
|
Mar 18
2021
|
John R Chiminski Executive Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
42,220
+17.02%
|
$1,519,920
$36.02 P/Share
|
|
Mar 18
2021
|
Steven L Fasman EVP & Chief Admin Officer |
SELL
Open market or private sale
|
Direct |
21,647
-12.12%
|
$2,251,288
$104.6 P/Share
|
|
Mar 18
2021
|
Steven L Fasman EVP & Chief Admin Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,647
+10.63%
|
$844,233
$39.95 P/Share
|
|
Feb 16
2021
|
Wetteny Joseph SVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-2.36%
|
$620,000
$124.92 P/Share
|
|
Feb 16
2021
|
Wetteny Joseph SVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+4.37%
|
$245,000
$49.41 P/Share
|
|
Feb 08
2021
|
Wetteny Joseph SVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,604
-8.46%
|
$520,252
$113.73 P/Share
|
|
Jan 21
2021
|
Ricci S Whitlow President, CSS |
SELL
Open market or private sale
|
Direct |
692
-21.18%
|
$81,656
$118.85 P/Share
|
|
Jan 11
2021
|
Karen Flynn Director |
SELL
Open market or private sale
|
Direct |
2,478
-3.4%
|
$277,536
$112.32 P/Share
|
|
Jan 06
2021
|
Scott Gunther SVP, Quality & Reg. Affairs |
SELL
Open market or private sale
|
Direct |
61
-0.37%
|
$6,344
$104.78 P/Share
|